Press Releases
-
108Labs Launches Colostrupedics™ Whole-Human Infant Formula with Secretory Antibodies
108Labs announces Colostrupedics™ whole-human infant formula, made possible with the discovery of novel secretory antibody biosynthesis. This is the first animal-free infant formula that exclusively comprises cell-cultured human milk molecules derived from human mammary cell agriculture and formulated with broadly-neutralizing human secretory antibodies.
Mar 7, 2021
-
Cytel’s East Bayes® Broadens & Simplifies Access to Complex Bayesian Clinical Trial Designs
Cytel has launched East Bayes®, an enhanced web-based extension of the East® platform that enables adoption of the most computationally intensive Bayesian clinical trial designs – without the need for powerful on-site computers.
Mar 7, 2021
-
Leinco Technologies, Inc. and La Jolla Institute for Immunology announce license agreement to develop novel COVID-19 diagnostic tools
Leinco Technologies, Inc., a premier developer and manufacturer of leading-edge recombinant proteins, antibodies, and conjugates, has signed a licensing agreement with La Jolla Institute for Immunology (LJI), one of the leading research organizations dedicated to studying the immune system, to develop novel COVID-19 diagnostics tools.
Mar 8, 2021
-
PCR Biosystems launches advanced Bst Polymerase reagents for accelerated DNA and RNA amplification
PCR Biosystems have launched a range of IsoFast™ Bst Polymerase reagents for rapid, robust and sensitive DNA and RNA amplification. Without the need for high temperature denaturation or specialised thermocycling equipment, IsoFast™ Bst Polymerase enables faster results and can be used in the field. This makes it ideal for a range of applications including environmental and food pathogen testing and clinical diagnostics – including for qualitative detection of the SARS-CoV-2 nucleic acid.
Mar 9, 2021
-
SB3000 ApS has been awarded a grant from the Danish Innovation Fund, to further refine its continuous manufacturing enabling technology μLOT® which will revolutionise the production of medicines
SB3000 received grant funding from Danish Innovation Fund for its continuous manufacturing enabling technology for medicine production.
Mar 9, 2021
-
PHARMASEAL’s Engility® platform fights off competition to be selected by award-winning US Medical Device company
-
Caroline O’Connor becomes new CCO of rare disease healthtech Raremark® amid rapid growth
-
Global rare disease specialist Raremark® appoints healthtech trailblazer Dale Jessop as new CTO
-
World first - biological evidence reveals scalp cooling physically protects hair from chemotherapy
Groundbreaking research announced ahead of World Cancer Day 2021, helps prove that scalp cooling protects hair follicles from chemotherapy drugs. A recent study, part of an innovative hair follicle research project carried out by the Scalp Cooling Research Centre at the University of Huddersfield, demonstrates how scalp cooling works and the mechanism behind its protection of the hair follicle.
Feb 15, 2021
-
Healthtech company Raremark® reboots as XperiomeTM to drive increased value for rare disease patients and researchers
-
Atik Cameras Supports the COVID-19 Fight with Wide Range of Advanced Imaging Solutions for Use with PCR Instruments
Atik Cameras, a specialist designer and manufacturer of advanced scientific imaging solutions, has further expanded its collaboration with leading global Original Equipment Manufacturers (OEMs) of real time Polymerase Chain Reaction (PCR) DNA amplifiers, securing multiple new contracts to supply high-performing cameras for reliable COVID-19 testing.
Feb 24, 2021
-
Saama Teams with Oracle to Offer Life Sciences Industry AI-Enabled Applications to Accelerate Clinical Trials
Saama and Oracle collaborate to bring game-changing, AI-powered smart applications to the Life Sciences industry to speed clinical development
Feb 28, 2021
-
Alfa Chemistry Materials Offers Battery Materials to Produce Organic and Printed Electronics
-
KCR opens new branch in Sydney, Australia
KCR, the international clinical development solutions provider, today announced the establishment of a new branch in Sydney, Australia. The new location will enhance KCR’s regional coverage and maximize clinical capabilities for clients across the globe.
Feb 24, 2021
-
Quinten spins off 50 data scientists to become a global leader in precision care using artificial intelligence and real-world data science
Quinten, a pioneer in AI-powered decision support solutions, has launched Quinten Health — a global and integrated analytical services and tools development offer.
Feb 28, 2021
-
Europital board forewarns that clinical deficits to slow biotech development in 2021
-
AARDEX Group and Pill Connect Ltd Partner to Empower Patient Adherence
-
Thermo Fisher Scientific Analytical Instruments Receive Prominent Industry Awards
Thermo Fisher Scientific’s latest announcement that its analytical instruments have been recognized through multiple respected industry awards.
Feb 15, 2021
-
Medivir licenses preclinical USP7 program to Ubiquigent
Ubiquigent announces it has entered an exclusive license agreement with Medivir AB to access their preclinical USP7 research program.
Feb 15, 2021
-
MedAI Releases Drug Formulation Development Service for the Pharmaceutical Industry